Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Practical Radiation Oncology
- Vol. 10 (1) , 29-35
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low‐risk patientHead & Neck, 2011
- Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neckHead & Neck, 2011
- Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Journal of Clinical Oncology, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastasesCancer, 2010
- Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinomaJournal of Surgical Oncology, 2008
- Radiation Therapy for Cutaneous Squamous Cell Carcinoma Involving the Parotid Area Lymph Nodes: Dose and Volume ConsiderationsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomesCancer, 2006
- Extent of Parotid Disease Influences Outcome in Patients With Metastatic Cutaneous Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2003
- The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skinBritish Journal of Radiology, 1983